Skip to content

Drug interactions

Gilteritinib + Memantine-donepezil

Severity: Moderate

Gilteritinib and Memantine-donepezil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both donepezil and gilteritinib can prolong the QT interval. Their combined use raises the risk of clinically significant QT prolongation and torsades de pointes, particularly with electrolyte abnormalities.

What this interaction means in plain words

Gilteritinib and Memantine-donepezil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Gilteritinib belongs to Oncology; Memantine-donepezil belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Additive effects on cardiac repolarization via QT prolongation.

What to do

Perform ECG monitoring at baseline and during therapy, and correct hypokalemia and hypomagnesemia. Consider interrupting or reducing the dose of gilteritinib if QTc becomes markedly prolonged.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gilteritinib and Memantine-donepezil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Gilteritinib with Memantine-donepezil?

MediHelp rates the interaction as moderate. Gilteritinib and Memantine-donepezil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both donepezil and gilteritinib can prolong the QT interval. Their combined use raises the risk of clinically significant QT prolongation and torsades de pointes, particularly with electrolyte abnormalities.

How serious is the interaction between Gilteritinib and Memantine-donepezil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Perform ECG monitoring at baseline and during therapy, and correct hypokalemia and hypomagnesemia. Consider interrupting or reducing the dose of gilteritinib if QTc becomes markedly prolonged.

What other medicines interact with Memantine-donepezil?

MediHelp also lists interactions of Memantine-donepezil with, for example, Dronedarone, Thioridazine, Amantadine. The full list is on the Memantine-donepezil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in